EnBio Holdings Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	12,630	10,668	9,575	8,120	8,987
Revenue Growth (YoY)	18.39%	11.42%	17.92%	-9.65%	31.39%
Cost of Revenue	8,942	8,014	7,092	5,355	6,562
Gross Profit	3,688	2,654	2,483	2,765	2,425
Selling, General & Admin	2,069	1,814	1,668	1,407	1,196
Operating Expenses	2,069	1,806	1,667	1,407	1,181
Operating Income	1,619	848	816	1,358	1,244
Interest Expense	-179	-141	-114	-124	-123
Interest & Investment Income	60	60	45	36	25
Currency Exchange Gain (Loss)	100	-27	186	65	80
Other Non Operating Income (Expenses)	-2	-39	133	8	-30
EBT Excluding Unusual Items	1,598	701	1,066	1,343	1,196
Gain (Loss) on Sale of Investments	238	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-2
Asset Writedown	-1	-9	-12	-110	-95
Other Unusual Items	-920	9	10	-	-1
Pretax Income	915	701	1,064	1,233	1,098
Income Tax Expense	663	281	326	437	392
Earnings From Continuing Operations	252	420	738	796	706
Minority Interest in Earnings	13	32	-30	16	-52
Net Income	265	452	708	812	654
Net Income to Common	265	452	708	812	654
Net Income Growth	-41.37%	-36.16%	-12.81%	24.16%	115.13%
Shares Outstanding (Basic)	8	8	8	7	7
Shares Outstanding (Diluted)	8	8	8	7	7
Shares Change (YoY)	0.08%	1.52%	20.11%	-0.01%	-0.03%
EPS (Basic)	32.69	55.81	88.75	122.26	98.52
EPS (Diluted)	32.69	55.81	88.75	122.26	98.47
EPS Growth	-41.42%	-37.11%	-27.41%	24.16%	115.19%
Free Cash Flow	119	-1,441	584	827	1,249
Free Cash Flow Per Share	14.68	-177.93	73.21	124.52	188.04
Dividend Per Share	-	9.000	8.000	8.000	8.000
Dividend Growth	-	12.50%	-	-	-
Gross Margin	29.20%	24.88%	25.93%	34.05%	26.98%
Operating Margin	12.82%	7.95%	8.52%	16.72%	13.84%
Profit Margin	2.10%	4.24%	7.39%	10.00%	7.28%
Free Cash Flow Margin	0.94%	-13.51%	6.10%	10.18%	13.90%
EBITDA	2,162	1,345	1,254	1,758	1,585
EBITDA Margin	17.12%	12.61%	13.10%	21.65%	17.64%
D&A For EBITDA	543	497	438	400	341
EBIT	1,619	848	816	1,358	1,244
EBIT Margin	12.82%	7.95%	8.52%	16.72%	13.84%
Effective Tax Rate	72.46%	40.09%	30.64%	35.44%	35.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.